Build Patient-Reported Outcomes Into Cancer Drug Dose Optimization, US FDA Says

 
• By Sue Sutter
Pie in the sky
The intent of dose optimization is not to achieve a 'mythical, pie in the sky' optimal dose, the FDA says. • Source: Shutterstock

More from Clinical Trials

More from R&D